Solve-Funded Phase 2 Observational Study Yields More Support for Repurposing Rapamycin to Reduce a Broad Range of ME/CFS Symptoms
Dr. Avik Roy is the chief scientific officer at the Simmaron Research Institute, a nonprofit
July 20, 2026
Dr. Avik Roy is the chief scientific officer at the Simmaron Research Institute, a nonprofit
In recognition of World ME Day, Solve M.E. announced today new funding for two award-winning
Dr. Liisa Selin, Dr. Ayano Kohlgruber, and Dr. Roshan Kumar received a Solve ME/CFS Catalyst
Glucagon-Like Peptide-1 (GLP-1) agonist medications, like semaglutide, are injectable or oral drugs that mimic the
In our “What’s New in ME/CFS?” series, we spotlight researchers transforming what we can do
Solve M.E. is proud to support two pioneering studies through our latest round of ME/CFS
In our What’s New in ME/CFS? series, we spotlight researchers transforming what we know –
Caring for someone with ME/CFS is an act of deep love–and preparation is one of
Why do so many people with ME/CFS share the same immune gene variants? That’s the
In our What’s New in ME/CFS? Series, we’respotlighting researchers who are not just studying this
What if the fact that ME/CFS looks different from person to person is actually the
It’s a turning point researchers wait years, even decades, for: results that replicate. In our